Blueteq News
Durvalumab – Cancer Drug Reimbursement, October 2026
Durvalumab (Imfinzi, AstraZeneca) has been approved for reimbursement in the Republic of Ireland through the Online Drug Management System (ODMS) in October 2026 for a
SMC Decisions – 12 October 2026
The Scottish Medicines Consortium (SMC) published advice on eight medicines following its meeting on 12 October 2026.3 Six medicines were accepted for use on the
Blueteq Brief October 2026 – England
Independent Review into Mental Health Conditions, ADHD and Autism On 9 October 2026, the Department of Health and Social Care (DHSC) published the Independent review
CYPRUS – GeSY — System Overview and Access Data
Cyprus’s national health system GeSY (General Healthcare System) marked its seventh anniversary in September 2026, with the Health Insurance Organisation (HIO) reporting 1,036,681 registered beneficiaries
RTÉ Investigates — Opioid prescribing under public drug schemes
An RTÉ Investigates analysis published on 28 September 2026 found that opioid prescribing under Ireland’s General Medical Services (GMS) scheme rose approximately 12% per eligible
AWMSG Annual Report 2025–26
The All Wales Medicines Strategy Group published its Annual Report for 2025–26 on 7 September 2026.1 The report records that 76 medicines were subject to
